Observing the course of cardiogenic shock in critical care patients
The Clinical and Hemodynamic Course of Cardiogenic Shocks Hospitalized in Critical Care
This study looks at patients in critical care with cardiogenic shock to see how their heart function changes and how it affects their chances of recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire, Amiens Academic / other |
| Locations | 1 site (Amiens) |
| Trial ID | NCT05752383 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients hospitalized in critical care units due to cardiogenic shock, a condition associated with high mortality rates. It aims to analyze clinical, biological, and hemodynamic data collected during their ICU stay to better understand the relationship between hemodynamic changes and in-hospital mortality. The study will utilize the vaso-inotropic score to monitor catecholamine levels and assess the impact of temporary mechanical circulatory support. By creating a cohort of cardiogenic shock patients, the study seeks to enhance knowledge of prognostic factors in this critical condition.
Who should consider this trial
Good fit: Ideal candidates include patients hospitalized in the ICU specifically for cardiogenic shock as defined by established criteria.
Not a fit: Patients with cardiogenic shock resulting from septic or hemorrhagic shock may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the management and outcomes of patients experiencing cardiogenic shock.
How similar studies have performed: Other studies have shown success in understanding cardiogenic shock through observational data, making this approach both relevant and valuable.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients hospitalized in ICU for cardiogenic shock * Patient with cardiogenic shock as defined by the FRENSCHOCK2 study criteria Exclusion Criteria: * Patient with cardiogenic shock in the context of septic shock and hemorrhagic shock
Where this trial is running
Amiens
- CHU Amiens Picardie — Amiens, France (Recruiting)
Study contacts
- Study coordinator: Christophe Beyls, MD
- Email: beyls.christophe@chu-amiens.fr
- Phone: 03 22 08 78 66
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.